3139 results for «3180»
3139 results
How to achieve successful outcome in contemporary CTO PCI
15 May 2024 – From EuroPCR 2024
New data on TAVI
16 May 2024 – From EuroPCR 2024
This session presents the latest research and data on transcatheter aortic valve implantation (TAVI). It covers a range of topics, including long-term results of TAVI versus surgical aortic valve replacement in low-risk severe aortic stenosis, real-world experience with novel transcatheter heart valve devices, outcomes in patients...
Feedback from Innovator's Exchange Hub
13 May 2024 – From EuroPCR 2024
TAVI: when calcifications are the major issues
16 May 2024 – From EuroPCR 2024
This session explores various challenging TAVI cases where severe aortic valve calcification was the main obstacle. Presenters share their experiences and strategies in overcoming these complex anatomical issues, including the use of techniques like the buddy balloon technique, snare technique, and innovative approaches to cross the...
Innovations in renal denervation: deja vu or reality?
13 May 2024 – From EuroPCR 2024
Feedback from Innovator's Exchange Hub
13 May 2024 – From EuroPCR 2024
ABC of cathlab education
16 May 2024 – From EuroPCR 2024
This session provides a comprehensive guide on educating and training new staff in the catheterization laboratory. Attendees will learn about effective teaching strategies, available educational tools, and how to create an optimal learning environment. The session covers topics such as onboarding new staff, utilizing simulation-based training,...
Innovations in heart failure: moving the heart forward
13 May 2024 – From EuroPCR 2024
PCI complications: stay vigilant to prevent, recognise and manage
16 May 2024 – From EuroPCR 2024
This session focuses on recognizing and managing serious PCI complications, with a particular emphasis on unique coronary artery disease presentations in Middle Eastern patients. Through interactive case discussions, attendees will learn how to prevent, identify, and effectively manage complications such as no-reflow, side branch compromise, and...
Is this patient a good candidate for Left Atrial Appendage Closure? An interactive rapid-fire discussion
16 May 2024 – From EuroPCR 2024
This interactive session focuses on selecting good candidates for left atrial appendage (LAA) closure procedures. It covers the key clinical elements driving the indication for LAA closure and the technical elements that make a case complex. Through a series of case presentations and discussions, the session...
How to obtain the best PCI results in calcified lesions
16 May 2024 – From EuroPCR 2024
This session features selected clinical case submissions that explore various strategies and techniques for achieving optimal PCI outcomes in patients with calcified coronary lesions. Participants will learn about plaque modification approaches, the use of IVUS guidance, and innovative ways to overcome the challenges posed by heavily...
Complications in CTO: is there a bailout?
16 May 2024 – From EuroPCR 2024
Watch this session on CTO complications and explore unique challenges and solutions, including a retrograde CTO technique with a twist, an unexpected outcome in a right coronary artery case, and an atypical perforation caused by an unexpected equipment issue. You’ll also see how a guide wire...
Management of LAA closure complications
16 May 2024 – From EuroPCR 2024
This session explores the various complications that can arise during left atrial appendage (LAA) closure procedures, including pericardial effusion, device embolisation, and procedural strokes. Learn how to identify risk factors, prevent these complications, and effectively manage them through case-based discussions and expert guidance.
Challenges and complications in STEMI: resuscitated cardiac arrest, left ventricular free wall rupture & more!
16 May 2024 – From EuroPCR 2024
This session presents a series of challenging and complex STEMI cases, highlighting the various complications that can arise during primary PCI. Attendees will witness real-life scenarios, including resuscitated cardiac arrest, the use of rotational atherectomy, left ventricular free wall rupture, and more. Through interactive discussions, the...
PCI of calcified lesions
16 May 2024 – From EuroPCR 2024
This session delves into the treatment of calcified lesions, providing a comprehensive overview of contemporary tools and techniques for optimal plaque modification. Attendees will learn through a series of case presentations, where experts dissect challenging cases involving severe coronary calcification, including in the left main trunk....
TAVI updates: expanding indications
14 May 2024 – From EuroPCR 2024
This session presents the latest updates and evidence on the expanding indications for transcatheter aortic valve implantation (TAVI). It covers topics such as the impact of unfavorable aortic valve anatomy on TAVI outcomes, sex-specific differences in cardiac damage in aortic stenosis patients undergoing TAVI, the use...
State-of-the-art on left main interventions in Latin America
16 May 2024 – From EuroPCR 2024
This session, in collaboration with the Sociedad Latino Americana de Cardiologia Intervencionista (SOLACI), provides insights into the management of left main coronary artery disease in Latin America. Attendees will learn about the revascularization guidelines for left main in the region, the approaches to left main bifurcations...
Trial updates and featured clinical research
16 May 2024 – From EuroPCR 2024
This session showcases a selection of the latest clinical research and trial updates presented at EuroPCR 2024. Attendees will have the opportunity to learn about the findings from studies evaluating the use of OCT-guided PCI for chronic total occlusions, the safety and efficacy of short dual...
Coronary issues before, during and after TAVI
16 May 2024 – From EuroPCR 2024
This session presents a series of challenging clinical cases highlighting the complex interplay between coronary artery disease and transcatheter aortic valve implantation (TAVI). Attendees will witness real-world scenarios, including high-risk PCI with concomitant severe aortic stenosis, the management of degenerated aortic bioprostheses with the risk of...
CTO PCI: from planning to execution
16 May 2024 – From EuroPCR 2024
This session, with the collaboration of the Cyprus Society of Cardiology / Cyprus Interventional Cardiology Working Group, Tunisian Group for Interventional Cardiology and Bulgarian Society of Interventional Cardiology, covers planning and execution of CTO PCI procedures. It includes case discussions on treatment dilemmas, overcoming frequently encountered...
